Hrt Financial LP Protara Therapeutics, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.38 - $9.3 $77,523 - $113,004	-12,151 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.68 - $16.99 $105,470 - $206,445	12,151 New	12,151 $118,000
Q3 2020 Nov 13, 2020	SELL	$16.76 - $31.89 $123,001 - $234,040	-7,339 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$22.0 - $60.7 $161,458 - $445,477	7,339 New	7,339 $215,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $25.8M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.